2269:HKG
WuXi Biologics (Cayman) Inc
48,20Â HKD
arrow_downward
−0,90%(−0,44) 1 d
16 okt., 16:08:14 GMT+8 · HKD
search
Alla symboler
| Symbol | Pris | Ändring | Ändring i procent |
|---|
insights_autoGenererar de viktigaste insikterna för 2269 …
Öppen
49,98Â HKD
Högt
50,85Â HKD
LÃ¥gt
45,82Â HKD
Börsvärde
198,43Â md
Genomsn. vol.
30,42Â mn
Volym
55,18Â mn
P/E-tal
34,48
52v högst
58,00Â HKD
52v lägst
28,48Â HKD
EPS
1,40Â HKD
Utestående aktier
1,23Â md
Antal anställda
15Â tn
Öppen
49,98Â HKD
Högt
50,85Â HKD
LÃ¥gt
45,82Â HKD
Börsvärde
198,43Â md
Genomsn. vol.
30,42Â mn
Volym
55,18Â mn
P/E-tal
34,48
52v högst
58,00Â HKD
52v lägst
28,48Â HKD
EPS
1,40Â HKD
Utestående aktier
1,23Â md
Antal anställda
15Â tn
Nyheter och artiklar
Från webbkällor och nyhetspartner
HurBra.se
·
för 2 dagar sedan
USA-börsen 15 oktober 2026: Vård lyfte, AI pressades
Bloomberg.com
·
för 51 minuter sedan
US Stock Futures Rise Ahead of Busy Earnings Week: Markets Wrap
Yahoo Finance
·
för 13 timmar sedan
Michael Burry Warns of a Stock Market ‘Supervolcano’
MarketWatch
·
för 8 timmar sedan
These surprising stocks could be some of the biggest drivers of S&P 500 earnings growth
Profil
WuXi Biologics is a global Contract Research Development and Manufacturing Organization that provides open-access, integrated technology platforms for biologics drug development.
WuXi Biologics' roots date back to 2010, when it was founded as a division of WuXi AppTec and began building out capabilities and facilities required for biologics discovery, development and good manufacturing practices. After being spun off from its parent, WuXi Biologics went public on the Hong Kong Stock Exchange in June 2017.
As of 2021, WuXi Biologics has 18 manufacturing sites including ten in China, three in the United States, two in Ireland, two in Germany, and one in Singapore.
In August 2020, WuXi Biologics was selected to become a component of the Hang Seng Index in Hong Kong.
In January 2024, WuXi Biologics' share price fell on news that the United States Congress had introduced legislation to block any federal government contracts with the company due to national security concerns. The concerns stem from allegations, denied by the company, that it has worked closely with the People's Liberation Army as a part of the Chinese Communist Party's military-civil fusion strategy. Wikipedia
Om WuXi Biologics (Cayman) Inc